Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.07
+0.08 (0.62%)
At close: Dec 5, 2025, 4:00 PM EST
12.60
-0.47 (-3.60%)
After-hours: Dec 5, 2025, 7:42 PM EST
Crescent Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 |
| Dec '24 Dec 31, 2024 |
| Net Income | -71.47 |
| Asset Writedown & Restructuring Costs | 4 |
| Stock-Based Compensation | 4.54 |
| Other Operating Activities | 0.01 |
| Change in Accounts Payable | 29.31 |
| Change in Other Net Operating Assets | 8.54 |
| Operating Cash Flow | -25.08 |
| Total Debt Issued | 149.92 |
| Net Debt Issued (Repaid) | 149.92 |
| Issuance of Common Stock | 1.26 |
| Other Financing Activities | -3.04 |
| Financing Cash Flow | 164.14 |
| Net Cash Flow | 139.06 |
| Change in Working Capital | 37.85 |
Source: S&P Capital IQ. Standard template.
Financial Sources.